Repurposed antiviral drugs make up the majority of Chinese research, with 9 phase III clinical trials of remdesivir in multiple countries with results expected in late April.
Dawa za kukinga virusi zilizotumika vingine zinajumuisha utafiti zaidi huko Uchina, na majaribio ya Awamu ya III ya remdesiviri katika nchi kadhaa kwa sababu ya ripoti kabla ya mwisho wa Aprili.